Human LONG®R³IGF-I

 
 

Biotech Reagents Ordering >> Full Product List >>

Description:

Human LONG™R³ Insulin-like Growth Factor-I (IGF-I) is an 83 amino acid analog of human IGF-I comprising the complete human IGF-I sequence with the substitution of an Arg for the Glu at position 3 (hence R³), and a 13 amino acid extension peptide at the N-terminus.

Recombinant LONG™R³IGF-I has been developed specifically for supplementation of mammalian cell culture to support the survival and proliferation of cells. It is engineered to have a higher biological potency than native IGF-I or IGF-II and has several advantages over recombinant insulin, potency being among them (1). Published research has shown that supplementation of cell cultures with LONG™R³IGF-I at a much lower concentration results in equivalent or better productivity than supplementation with standard concentrations of insulin. LONG™R³IGF-I is better able to stimulate the Type I IGF receptor and thus induce a higher level of activation of intracellular signaling molecules which are responsible for promoting cell survival by inhibition of apoptosis (1).

*SAFC Biosciences has exclusive marketing and distribution rights for LONG™R3IGF-I for use in industrial mammalian cell culture.

For information on using or ordering LONG™R³IGF-I for industrial cell culture, please click here or visit the SAFC Biosciences website: www.SAFCBiosciences.com

LONG is a trademark owned by GroPep Limited

LONGTMR3IGF-I is covered by the following patents assigned to GroPep:

US Patent 5,330,971 and 5,164,370; European Patent 429,586; Japanese Patent 2,682738, Australian Patent 633,099; Canadian Patent 2,033,176

References:

1. Yandell C., et al. (2004) An analogue of IGF-I. BioProcess International 2, 56-64

Source:

Produced recombinantly

Purity:

> 85 % (by HPLC)

Molecular Weight:

9110 +/- 2 daltons – confirmed by Mass Spectrometry

N-terminal sequence analysis:

18 residues > 95 % single sequence

Biological Activity:

Type 1 IGF receptor binding assay: ED50 > 15 ng/ml
IGF binding protein assay: ED50 > 200 ng/ml
Stimulation of protein synthesis in rat L6 myoblasts: ED50 < 10 ng/ml

Endotoxin:

< 0.1 EU/µg

State and Appearance:

Lyophilized white powder
Dried from 100 mM acetic acid and stored under nitrogen at a slight vacuum

Storage/Stability:

At least 2 years at 2 - 4°C (lyophilized)

Reconstitution:

100 mM acetic acid at a concentration of > 1 mg/ml

Reconstitution:

#1200: Handling of Novozymes GroPep LONG®R³IGF-I for use in Cell Culture

Detection:

#3030 Procedure for Human LONG®R³IGF-I Double monoclonal ELISA (BK / MAN1 / MAO1)

Product Performance:

Related Links:


      Protein Synthesis:



Tick box to order:

Product Codes:

AU200     200 µg    

AM001     1 mg    

AM005     5 mg    

AM010     10 mg    

AM020     20 mg    

**NOT FOR USE IN HUMANS**


Print Product Specification Sheet
Version Information: 03.09.09

 

 
 

Novozymes GroPep: A biotechnology company serving the research, cell culture, and IGF markets.
Copyright  •  Disclaimer  •  Privacy  •  Download Acrobat Reader